Immunotherapy of malignant disease (Part 2)
MacGregor, A.B.; Falk, R.E.
Journal of the Royal College of Surgeons of Edinburgh 21(1): 43-49
1976
ISSN/ISBN: 0035-8835 PMID: 765453 Document Number: 104859
Document emailed within 1 workday
Related Documents
Perlin, E. 1979: Immunotherapy in patients with oral malignant disease Otolaryngologic Clinics of North America 12(1): 195-199Klein, E. 1979: Introduction--immunological reactions and immunotherapy of malignant disease Advances in Experimental Medicine and Biology 114: 717-725
Yu, S.S.; Dorff, T.B.; Ballas, L.K.; Sadeghi, S.; Skinner, E.C.; Quinn, D.I. 2017: Immunotherapy in urothelial cancer, part 1: T-cell checkpoint inhibition in advanced or metastatic disease Clinical Advances in Hematology and Oncology: H&o 15(6): 466-477
John, C. 1983: Ultrasonic examination of the abdomen in malignant disease. Part 3. the female reproductive system Radiography 49(581): 109-116
Jaspersen, D. 1992: The CUP syndrome--malignant disease with unknown primary tumor. Part 4: Therapy and prognosis Fortschritte der Medizin 110(31): 587-588
Hermann, R. 1978: Immunotherapy of malignant tumors Deutsche Medizinische Wochenschrift 103(43): 1716
Bubeník, J. 1989: Perspectives in immunotherapy of malignant tumors Casopis Lekaru Ceskych 128(28): 865-867
Matthias, M. 1975: Chemo- and immunotherapy of malignant neoplasms Zeitschrift für Arztliche Fortbildung 69(11): 580-584
Johnstone, D.E. 1981: Immunotherapy in children: past, present, and future. (Part I) Annals of Allergy 46(1): 1-7
Yoshida, S.; Takai, N.; Saito, T.; Tanaka, R. 1987: Adoptive immunotherapy in patients with malignant glioma Gan to Kagaku Ryoho. Cancer and ChemoTherapy 14(6 Part 1): 1930-1932
Okuno, K.; Sugiura, F.; Sukegawa, Y.; Inoue, K. 2012: New directions in immunotherapy for malignant solid tumors Nihon Rinsho. Japanese Journal of Clinical Medicine 70(12): 2075-2086
Lotem, M.; Shiloni, E.; Ingber, A.; Peretz, T. 1997: Active specific immunotherapy of malignant melanoma Harefuah 133(3-4): 122-126
Kristensen, E. 1976: Use of immunotherapy in the treatment of malignant melanoma of the skin Ugeskrift for Laeger 138(8): 468-473
Knerich, R.; Adinolfi, D.; Silvani, V.; Robustelli della Cuna, G.; Spanu, G.; Preti, P.; Rodriguez y Baena, R. 1984: Chemotherapy and immunotherapy of intracranial malignant gliomas Minerva Medica 75(21): 1333-1340
Mutzner, P.A.; Stuhlmiller, G.M.; Seigler, H.F.; Stumpf, W.E.; Sar, M. 1981: Basis for a specific-active immunotherapy in malignant melanoma Schweizerische Medizinische Wochenschrift 111(36): 1322-1325
Kovarík, J.; Ninger, E.; Mechl, Z.; Zemanová, D.; Lauerová, L.; Sopková, B.; Svejda, J.; Bacovský, B.; Bártová, A.; Bártek, J. 1983: Immunotherapy and immune competence of patients with malignant melanoma Czechoslovak Medicine 6(3): 172-174
Grinevich, I.A. 1991: Nonspecific active immunotherapy in the combined treatment of malignant neoplasms Vrachebnoe Delo 5: 8-11
Yamasaki, T.; Kikuchi, H. 1989: An experimental approach to specific adoptive immunotherapy for malignant brain tumors Nihon Geka Hokan. Archiv für Japanische Chirurgie 58(6): 485-492
Clavel, B. 1974: Medical treatment of malignant bone tumors (carcinolytics, hormonotherapy, immunotherapy) La Semaine des Hopitaux: Organe Fonde Par l'Association d'Enseignement Medical des Hopitaux de Paris 50(4): 287-295
Spitler, L.E.; Wong, P.; Sagebiel, R. 1978: Combined immunotherapy of malignant melanoma. Unusual survival following cerebral metastasis Archives of Dermatology 114(10): 1501-1504